Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bicycle Therapeutics
Biotech
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders
BridgeBio spins out oncology company. Ipsen names new North America chief. George Medicines taps ex-Ironwood CEO for same role.
Max Bayer
,
Gabrielle Masson
May 3, 2024 8:30am
Bicycle reveals another $1.7B deal, this time with Bayer
May 10, 2023 9:05am
Amarin CEO abruptly resigns—Chutes & Ladders
Apr 7, 2023 9:30am
Novartis-Bicycle radiopharmaceuticals deal could cruise to $1.7B
Mar 28, 2023 10:35am
Genentech rides up to 2nd oncology target in Bicycle collab
Jul 12, 2022 10:28am
Ionis pays $45M to expand oligonucleotide delivery toolkit
Jul 13, 2021 8:20am
